March 19, 2020 — The global pandemic caused by SARS-CoV-2 presents a public health crisis, as well as unprecedented challenges in the conduct of clinical trials. Join us to learn how clinical teams are leveraging technology to quickly and efficiently gain visibility into their clinical samples across sites, labs, and storage facilities.
Sponsors are adapting to the new reality of increased remote site monitoring, addressing disruptions in site visits, and planning for uncertain shipping logistics – all while responding to guidance from the FDA and EMA requiring documentation of discrepancies. These obstacles require innovative solutions which accommodate the increasingly remote workforce.
Join us to learn how clinical teams are leveraging technology to quickly and efficiently gain visibility into their clinical samples across sites, labs, and storage facilities.
You’ll see how this approach:
- Enables early detection of discrepancies, with dashboard alerts and a collaborative interface
- Captures information regulatory agencies require for documentation of COVID-19 impacts
- Provides forward looking visibility into expected sample collection, including as sample schedules may be forced to evolve
- Delivers insights quickly through rapid deployment
- And much more!
